Home » Topics » Regulatory » Patents

Patents
RSS

IL-2 receptor-binding polypeptide described by Boehringer Ingelheim

Sep. 13, 1996

The Liposome Company prepares and formulates new taxanes

Sep. 13, 1996

Improved camptothecin derivatives

Sep. 13, 1996

New consensus interferon from Amgen

Sep. 13, 1996

Inhibitors of cytokine production reported by SmithKline Beecham

Sep. 13, 1996

Procter & Gamble discloses new matrix metalloproteinase inhibitors

Sep. 13, 1996

COX-2 inhibitors from Merck Frosst

Sep. 13, 1996

New HIV protease inhibitors from Searle

Sep. 13, 1996

Merck & Co. discloses novel antifungal agent

Sep. 13, 1996

Natural antibacterial agent reported by Korean researchers

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.